GMED
Globus Medical
Stock NYSE – Stock Market Prices, News & Analysis
Globus Medical is a company specialized in the design, development, and marketing of medical devices primarily used in spinal surgery.
Globus Medical
GMED
Globus Medical is a company specialized in the design, development, and marketing of medical devices primarily used in spinal surgery.
Price history of Globus Medical
Price history of Globus Medical
Performance & Momentum
Globus Medical jumps 39% on raised 2025 outlook
Globus Medical (GMED) reported strong Q3 2025 results, with revenue of $769 million and net income of $119 million, largely driven by its recent Nevro acquisition. Buoyed by this performance, the company raised its full-year 2025 revenue and profit guidance, benefiting from improved margins and acquisition synergies. This positive momentum also reflects increased investments in product innovation and global production expansion, strengthening its growth prospects.
Strategic Analysis
Globus Medical • 2026
Globus Medical positions itself as an innovative player specializing in medical devices for spinal surgery, combining technical expertise with a strong product innovation capability. Its differentiation is based on an advanced technological portfolio and solutions tailored to the specific needs of orthopedic surgeons.
Strengths
- Technological leadership in a niche segment with high barriers to entry
- Sustained growth driven by increasing demand in spinal surgery
- Diversified portfolio of recognized implants and surgical instruments
Weaknesses
- Revenue concentration in a single therapeutic segment
- Dependence on regulatory changes and health reimbursements
Momentum
The robust momentum indicates stable business dynamics and good visibility on mid-term growth, supported by product innovations and the gradual adoption of its technologies. However, the absence of recent news calls for monitoring future catalysts to maintain this trend.
Similar stocks to Globus Medical
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
